Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Reach by phone at (949) 868-6870, AI-powered chat through the website and patient portal, and email at [email protected] with roughly one-day response times
As of 2026, retatrutide has not been approved by the MHRA, FDA, EMA, or any other regulatory authority for human or veterinary use
Research subjects heart shifts from IGF-1 production to utilization with chronic heart [PMID: 31267324] Laboratory literature summary: research subjects heart shifts from IGF-1 production to utilization with chronic heart failure
For example, in a 48-week trial, retatrutide induced body weight reductions of ~24% in some groups
Adults seeking energy and metabolism support
US$ 29.82
US$ 26.43
US$ 24.10
US$ 24.75
:max_bytes(150000):strip_icc()/Health-GettyImages-2200929852-cbe13f76512c4cd3b51252536927920f.jpg)
